Evaluation of Geriatric Questionnaires to Predict Toxicities of CDK 4/6 Inhibitors in Older Breast Cancer Patients?

Condition:   Can the Geriatric Questionnaires Predict Adverse Effects in Geriatric Breast Cancer Patients Treated With Cyclin-dependent Kinase 4 and 6 Inhibitors Intervention:   Drug: Palbociclib 125mg and Ribociclib 600 mg Sponsor:   Namik Kemal University Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials